BioSpace News Archive

Mind Medicine Inc., the leading psychedelic pharmaceutical company, is pleased to announce that the Company has graduated from the OTC Pink Open Market to the OTCQB Venture Market.

To mark the 30th Anniversary of World Haemophilia Day, Sobi™ have released the 2020 Haemophilia Index which examines the quality of life for people with haemophilia in Europe, and the reach of humanitarian aid across the globe.

Teleflex Incorporated announced that its 2020 annual meeting of stockholders will be conducted exclusively online by remote communication due to public health concerns regarding COVID-19 and government-recommended and required limits on gatherings and events, and to support the health and well-being of our stockholders, employees, directors and other participants.

Maryland tech entrepreneur and investor Matthew Siegal today announced that his latest tech venture, Potomac, Maryland-based Transformania LLC, has suspended operations indefinitely so that Siegal and Transformania President and CEO, Daniel Levinson, can work full-time on answering the appeal for face masks and other personal protective equipment from hospitals and government agencies

The presence of multiple players has fragmented the Latin America pharmaceutical products and CMO market.

The consequences of lifestyle diseases are aplenty. One condition like obesity, hypertension, or diabetes which are also result of stress, can be dangerous to the entire body.

Medicinal services related contaminations or careful site diseases are the diseases procured among patients amid their emergency clinic remain, making requirements for careful disease control.

Highlight Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces that it has changed its name from Bioncotech with immediate effect.

UK diagnostics firm Intelligent Fingerprinting – developers of the world’s only portable fingerprint-based drug screening system – believes that the highly sensitive fluorescence measurement capabilities of its lateral flow technology and portable instrumentation could have a valuable role to play in accelerating Coronavirus diagnostic testing at the point of care.

OliX Pharmaceuticals , Inc. (KOSDAQ: 226950), a key player in the development of RNAi therapeutics, today announced the appointment of Dr. Gordon Jiang, Dr. Aaron Hakim and Dr. Yury V. Popov to its Scientific Advisory Board (SAB). The SAB will work with OliX Pharmaceuticals executive team to refine the emerging pipeline as well as clinical strategy for the company’s assets. “We are pleased to welcome Dr. Jiang, Dr. Hakim and Dr.